StonvexLoading…
StonvexStonvexStonvexCore line items from BEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.76B | $4.62B | $2.33B | $8.77B | $6.43B |
Operating Income | Not available | $604.30M | $281.00M | $604.10M | $518.70M |
Net Income | Not available | $523.70M | $255.50M | $524.90M | $407.30M |
EPS (Diluted) | $0.64 | $0.95 | $0.46 | $0.91 | $0.70 |
Total Assets | Not available | $34.11B | $32.55B | $32.37B | $32.55B |
Total Liabilities | Not available | $19.49B | $18.16B | $18.18B | $18.12B |
Cash & Equivalents | Not available | $3.57B | $3.48B | $3.57B | $3.96B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $911.60M | $963.50M |
Shares Outstanding | Not available | 519.62M | 519.97M | 520.95M | 518.37M |